nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—CYP1A1—breast cancer	0.083	0.343	CbGaD
Nifedipine—CYP2D6—breast cancer	0.0618	0.255	CbGaD
Nifedipine—CYP3A4—breast cancer	0.053	0.219	CbGaD
Nifedipine—ABCB1—breast cancer	0.0441	0.182	CbGaD
Nifedipine—CYP2A6—Letrozole—breast cancer	0.0304	0.0671	CbGbCtD
Nifedipine—CYP1A1—Toremifene—breast cancer	0.0212	0.0467	CbGbCtD
Nifedipine—ABCC3—Fluorouracil—breast cancer	0.015	0.0332	CbGbCtD
Nifedipine—CYP2B6—Thiotepa—breast cancer	0.0134	0.0295	CbGbCtD
Nifedipine—CYP1A2—Anastrozole—breast cancer	0.0103	0.0228	CbGbCtD
Nifedipine—CYP1A2—Toremifene—breast cancer	0.00945	0.0209	CbGbCtD
Nifedipine—CYP2C9—Anastrozole—breast cancer	0.00931	0.0206	CbGbCtD
Nifedipine—CYP3A5—Lapatinib—breast cancer	0.00926	0.0205	CbGbCtD
Nifedipine—ABCC2—Tamoxifen—breast cancer	0.00926	0.0205	CbGbCtD
Nifedipine—CYP2A6—Tamoxifen—breast cancer	0.00905	0.02	CbGbCtD
Nifedipine—CYP2B6—Raloxifene—breast cancer	0.00891	0.0197	CbGbCtD
Nifedipine—CYP2C8—Lapatinib—breast cancer	0.00891	0.0197	CbGbCtD
Nifedipine—ABCC3—Doxorubicin—breast cancer	0.00855	0.0189	CbGbCtD
Nifedipine—ABCC3—Methotrexate—breast cancer	0.00828	0.0183	CbGbCtD
Nifedipine—ABCB1—Toremifene—breast cancer	0.00826	0.0183	CbGbCtD
Nifedipine—CYP1A1—Tamoxifen—breast cancer	0.00773	0.0171	CbGbCtD
Nifedipine—ABCC2—Paclitaxel—breast cancer	0.00721	0.0159	CbGbCtD
Nifedipine—CYP3A4—Exemestane—breast cancer	0.00714	0.0158	CbGbCtD
Nifedipine—ABCC2—Irinotecan—breast cancer	0.00711	0.0157	CbGbCtD
Nifedipine—CYP2C9—Idarubicin—breast cancer	0.00706	0.0156	CbGbCtD
Nifedipine—ABCC2—Carboplatin—breast cancer	0.00678	0.015	CbGbCtD
Nifedipine—CYP2C8—Raloxifene—breast cancer	0.00675	0.0149	CbGbCtD
Nifedipine—CYP2A6—Fluorouracil—breast cancer	0.00667	0.0147	CbGbCtD
Nifedipine—CYP2D6—Idarubicin—breast cancer	0.00645	0.0143	CbGbCtD
Nifedipine—ABCC2—Vinblastine—breast cancer	0.00632	0.014	CbGbCtD
Nifedipine—CYP3A7—Tamoxifen—breast cancer	0.00618	0.0137	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.00618	0.0137	CbGbCtD
Nifedipine—CYP3A4—Letrozole—breast cancer	0.00607	0.0134	CbGbCtD
Nifedipine—ABCB1—Lapatinib—breast cancer	0.00603	0.0133	CbGbCtD
Nifedipine—CYP2E1—Tamoxifen—breast cancer	0.00597	0.0132	CbGbCtD
Nifedipine—CYP2B6—Tamoxifen—breast cancer	0.00589	0.013	CbGbCtD
Nifedipine—CYP2E1—Mitoxantrone—breast cancer	0.00582	0.0129	CbGbCtD
Nifedipine—CYP3A4—Anastrozole—breast cancer	0.00541	0.012	CbGbCtD
Nifedipine—ABCC2—Docetaxel—breast cancer	0.00521	0.0115	CbGbCtD
Nifedipine—CYP3A4—Toremifene—breast cancer	0.00495	0.0109	CbGbCtD
Nifedipine—CYP3A7—Paclitaxel—breast cancer	0.00481	0.0106	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00481	0.0106	CbGbCtD
Nifedipine—CYP3A7—Irinotecan—breast cancer	0.00475	0.0105	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00475	0.0105	CbGbCtD
Nifedipine—CYP3A5—Tamoxifen—breast cancer	0.00464	0.0102	CbGbCtD
Nifedipine—CYP3A4—Fulvestrant—breast cancer	0.0046	0.0102	CbGbCtD
Nifedipine—CYP2B6—Irinotecan—breast cancer	0.00452	0.00999	CbGbCtD
Nifedipine—CYP2C8—Tamoxifen—breast cancer	0.00446	0.00985	CbGbCtD
Nifedipine—CYP3A4—Thiotepa—breast cancer	0.0041	0.00906	CbGbCtD
Nifedipine—ABCC2—Doxorubicin—breast cancer	0.00388	0.00858	CbGbCtD
Nifedipine—CYP2C9—Capecitabine—breast cancer	0.00387	0.00854	CbGbCtD
Nifedipine—ABCC2—Methotrexate—breast cancer	0.00376	0.00831	CbGbCtD
Nifedipine—CYP3A4—Ixabepilone—breast cancer	0.00375	0.00829	CbGbCtD
Nifedipine—CYP3A4—Lapatinib—breast cancer	0.00361	0.00798	CbGbCtD
Nifedipine—CYP3A5—Paclitaxel—breast cancer	0.00361	0.00798	CbGbCtD
Nifedipine—CYP3A5—Irinotecan—breast cancer	0.00356	0.00787	CbGbCtD
Nifedipine—CYP3A7—Docetaxel—breast cancer	0.00348	0.00769	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00348	0.00769	CbGbCtD
Nifedipine—CYP2C8—Paclitaxel—breast cancer	0.00347	0.00767	CbGbCtD
Nifedipine—CYP1A2—Tamoxifen—breast cancer	0.00345	0.00763	CbGbCtD
Nifedipine—ABCB1—Vinorelbine—breast cancer	0.00334	0.00739	CbGbCtD
Nifedipine—CYP2C8—Fluorouracil—breast cancer	0.00329	0.00726	CbGbCtD
Nifedipine—CYP2D6—Vinorelbine—breast cancer	0.00315	0.00696	CbGbCtD
Nifedipine—CYP2C9—Tamoxifen—breast cancer	0.00311	0.00687	CbGbCtD
Nifedipine—ABCB1—Tamoxifen—breast cancer	0.00302	0.00667	CbGbCtD
Nifedipine—ABCB1—Mitoxantrone—breast cancer	0.00294	0.0065	CbGbCtD
Nifedipine—CYP2D6—Tamoxifen—breast cancer	0.00284	0.00628	CbGbCtD
Nifedipine—CYP3A4—Raloxifene—breast cancer	0.00274	0.00605	CbGbCtD
Nifedipine—CYP3A5—Docetaxel—breast cancer	0.00261	0.00577	CbGbCtD
Nifedipine—ABCB1—Gemcitabine—breast cancer	0.0026	0.00575	CbGbCtD
Nifedipine—CYP1A2—Fluorouracil—breast cancer	0.00254	0.00562	CbGbCtD
Nifedipine—CYP2B6—Doxorubicin—breast cancer	0.00247	0.00546	CbGbCtD
Nifedipine—CYP2C9—Paclitaxel—breast cancer	0.00242	0.00535	CbGbCtD
Nifedipine—ABCB1—Paclitaxel—breast cancer	0.00235	0.00519	CbGbCtD
Nifedipine—ABCB1—Irinotecan—breast cancer	0.00232	0.00512	CbGbCtD
Nifedipine—CYP2C9—Fluorouracil—breast cancer	0.00229	0.00506	CbGbCtD
Nifedipine—ABCB1—Vinblastine—breast cancer	0.00206	0.00455	CbGbCtD
Nifedipine—CYP3A4—Vinorelbine—breast cancer	0.002	0.00443	CbGbCtD
Nifedipine—CYP2D6—Vinblastine—breast cancer	0.00194	0.00429	CbGbCtD
Nifedipine—CYP3A4—Tamoxifen—breast cancer	0.00181	0.004	CbGbCtD
Nifedipine—CYP3A4—Mitoxantrone—breast cancer	0.00176	0.0039	CbGbCtD
Nifedipine—ABCB1—Docetaxel—breast cancer	0.0017	0.00375	CbGbCtD
Nifedipine—CYP3A4—Paclitaxel—breast cancer	0.00141	0.00311	CbGbCtD
Nifedipine—CYP3A4—Irinotecan—breast cancer	0.00139	0.00307	CbGbCtD
Nifedipine—ABCB1—Doxorubicin—breast cancer	0.00127	0.0028	CbGbCtD
Nifedipine—CYP3A4—Vinblastine—breast cancer	0.00123	0.00273	CbGbCtD
Nifedipine—ABCB1—Methotrexate—breast cancer	0.00123	0.00271	CbGbCtD
Nifedipine—CYP2D6—Doxorubicin—breast cancer	0.00119	0.00264	CbGbCtD
Nifedipine—CYP3A4—Docetaxel—breast cancer	0.00102	0.00225	CbGbCtD
Nifedipine—CACNA2D1—mammary gland—breast cancer	0.000986	0.0297	CbGeAlD
Nifedipine—CYP3A4—Doxorubicin—breast cancer	0.000759	0.00168	CbGbCtD
Nifedipine—CALM3—mammary gland—breast cancer	0.00071	0.0214	CbGeAlD
Nifedipine—CALM3—nipple—breast cancer	0.000587	0.0177	CbGeAlD
Nifedipine—CALM1—mammary gland—breast cancer	0.000555	0.0167	CbGeAlD
Nifedipine—CACNA1H—uterus—breast cancer	0.000512	0.0154	CbGeAlD
Nifedipine—CACNA1H—pituitary gland—breast cancer	0.000503	0.0151	CbGeAlD
Nifedipine—CACNB2—pituitary gland—breast cancer	0.000475	0.0143	CbGeAlD
Nifedipine—CYP2C8—mammary gland—breast cancer	0.000462	0.0139	CbGeAlD
Nifedipine—CALM2—nipple—breast cancer	0.000461	0.0139	CbGeAlD
Nifedipine—CACNA1H—female reproductive system—breast cancer	0.00046	0.0138	CbGeAlD
Nifedipine—CALM1—nipple—breast cancer	0.000459	0.0138	CbGeAlD
Nifedipine—CACNA1H—adrenal gland—breast cancer	0.000449	0.0135	CbGeAlD
Nifedipine—CACNA2D1—adipose tissue—breast cancer	0.000444	0.0134	CbGeAlD
Nifedipine—Nimodipine—AHR—breast cancer	0.000437	0.182	CrCbGaD
Nifedipine—CACNB2—adrenal gland—breast cancer	0.000424	0.0128	CbGeAlD
Nifedipine—CACNA1H—female gonad—breast cancer	0.000419	0.0126	CbGeAlD
Nifedipine—CACNA1D—pituitary gland—breast cancer	0.000415	0.0125	CbGeAlD
Nifedipine—CYP3A7—endocrine gland—breast cancer	0.000415	0.0125	CbGeAlD
Nifedipine—CYP2C9—mammary gland—breast cancer	0.00041	0.0123	CbGeAlD
Nifedipine—CACNA2D1—adrenal gland—breast cancer	0.000398	0.012	CbGeAlD
Nifedipine—CACNA1H—endocrine gland—breast cancer	0.000389	0.0117	CbGeAlD
Nifedipine—CACNA2D1—bone marrow—breast cancer	0.000385	0.0116	CbGeAlD
Nifedipine—CACNA1C—pituitary gland—breast cancer	0.000383	0.0115	CbGeAlD
Nifedipine—CACNA1C—adipose tissue—breast cancer	0.000381	0.0115	CbGeAlD
Nifedipine—CALM2—embryo—breast cancer	0.00038	0.0114	CbGeAlD
Nifedipine—CALM1—embryo—breast cancer	0.000379	0.0114	CbGeAlD
Nifedipine—CACNA2D1—female gonad—breast cancer	0.000371	0.0112	CbGeAlD
Nifedipine—CACNA1D—adrenal gland—breast cancer	0.000371	0.0112	CbGeAlD
Nifedipine—CYP2A6—adipose tissue—breast cancer	0.00037	0.0111	CbGeAlD
Nifedipine—CYP1A2—nipple—breast cancer	0.000358	0.0108	CbGeAlD
Nifedipine—CALM3—endometrium—breast cancer	0.000355	0.0107	CbGeAlD
Nifedipine—CYP1A1—nipple—breast cancer	0.000353	0.0106	CbGeAlD
Nifedipine—CACNA1C—female reproductive system—breast cancer	0.000351	0.0106	CbGeAlD
Nifedipine—ABCC3—adipose tissue—breast cancer	0.000347	0.0104	CbGeAlD
Nifedipine—CACNA2D1—endocrine gland—breast cancer	0.000345	0.0104	CbGeAlD
Nifedipine—CACNA1C—adrenal gland—breast cancer	0.000342	0.0103	CbGeAlD
Nifedipine—CALM3—uterus—breast cancer	0.000327	0.00983	CbGeAlD
Nifedipine—CACNA1D—endocrine gland—breast cancer	0.000321	0.00967	CbGeAlD
Nifedipine—CALM3—pituitary gland—breast cancer	0.000321	0.00965	CbGeAlD
Nifedipine—CALM3—adipose tissue—breast cancer	0.000319	0.00961	CbGeAlD
Nifedipine—ABCC3—female reproductive system—breast cancer	0.000319	0.0096	CbGeAlD
Nifedipine—ABCC3—adrenal gland—breast cancer	0.000311	0.00937	CbGeAlD
Nifedipine—CALM2—epithelium—breast cancer	0.00031	0.00934	CbGeAlD
Nifedipine—CALM1—epithelium—breast cancer	0.000309	0.0093	CbGeAlD
Nifedipine—CACNA1C—endocrine gland—breast cancer	0.000297	0.00893	CbGeAlD
Nifedipine—CALM2—skin of body—breast cancer	0.000295	0.00889	CbGeAlD
Nifedipine—CALM1—skin of body—breast cancer	0.000294	0.00884	CbGeAlD
Nifedipine—ABCC3—female gonad—breast cancer	0.00029	0.00873	CbGeAlD
Nifedipine—CALM3—adrenal gland—breast cancer	0.000287	0.00862	CbGeAlD
Nifedipine—CALM2—endometrium—breast cancer	0.000278	0.00838	CbGeAlD
Nifedipine—CALM3—bone marrow—breast cancer	0.000277	0.00834	CbGeAlD
Nifedipine—CALM1—endometrium—breast cancer	0.000277	0.00834	CbGeAlD
Nifedipine—ABCC3—endocrine gland—breast cancer	0.00027	0.00812	CbGeAlD
Nifedipine—CACNA1H—lymph node—breast cancer	0.000269	0.0081	CbGeAlD
Nifedipine—CALM3—female gonad—breast cancer	0.000267	0.00804	CbGeAlD
Nifedipine—CALM2—uterus—breast cancer	0.000257	0.00772	CbGeAlD
Nifedipine—CALM1—uterus—breast cancer	0.000255	0.00768	CbGeAlD
Nifedipine—ABCC2—female reproductive system—breast cancer	0.000255	0.00767	CbGeAlD
Nifedipine—CACNB2—lymph node—breast cancer	0.000254	0.00765	CbGeAlD
Nifedipine—CALM2—pituitary gland—breast cancer	0.000252	0.00758	CbGeAlD
Nifedipine—CALM2—adipose tissue—breast cancer	0.000251	0.00755	CbGeAlD
Nifedipine—CALM1—pituitary gland—breast cancer	0.000251	0.00755	CbGeAlD
Nifedipine—CALM1—adipose tissue—breast cancer	0.00025	0.00752	CbGeAlD
Nifedipine—ABCC2—adrenal gland—breast cancer	0.000249	0.00748	CbGeAlD
Nifedipine—CACNA2D1—lymph node—breast cancer	0.000239	0.00718	CbGeAlD
Nifedipine—CYP1A1—epithelium—breast cancer	0.000238	0.00715	CbGeAlD
Nifedipine—CYP2C8—endometrium—breast cancer	0.000231	0.00694	CbGeAlD
Nifedipine—CALM2—female reproductive system—breast cancer	0.000231	0.00694	CbGeAlD
Nifedipine—CALM1—female reproductive system—breast cancer	0.00023	0.00691	CbGeAlD
Nifedipine—CYP1A1—skin of body—breast cancer	0.000226	0.0068	CbGeAlD
Nifedipine—CALM2—adrenal gland—breast cancer	0.000225	0.00677	CbGeAlD
Nifedipine—CALM1—adrenal gland—breast cancer	0.000224	0.00674	CbGeAlD
Nifedipine—CACNA1D—lymph node—breast cancer	0.000222	0.00669	CbGeAlD
Nifedipine—CYP2B6—skin of body—breast cancer	0.00022	0.00661	CbGeAlD
Nifedipine—CALM2—bone marrow—breast cancer	0.000218	0.00655	CbGeAlD
Nifedipine—CALM1—bone marrow—breast cancer	0.000217	0.00652	CbGeAlD
Nifedipine—ABCC2—endocrine gland—breast cancer	0.000216	0.00649	CbGeAlD
Nifedipine—CALM2—female gonad—breast cancer	0.00021	0.00631	CbGeAlD
Nifedipine—CALM1—female gonad—breast cancer	0.000209	0.00629	CbGeAlD
Nifedipine—CYP2C8—pituitary gland—breast cancer	0.000209	0.00628	CbGeAlD
Nifedipine—CACNA1C—lymph node—breast cancer	0.000205	0.00617	CbGeAlD
Nifedipine—Clevidipine—BCHE—breast cancer	0.000199	0.0825	CrCbGaD
Nifedipine—CYP1A1—uterus—breast cancer	0.000196	0.00591	CbGeAlD
Nifedipine—CALM2—endocrine gland—breast cancer	0.000195	0.00587	CbGeAlD
Nifedipine—CALM1—endocrine gland—breast cancer	0.000194	0.00585	CbGeAlD
Nifedipine—CYP1A1—adipose tissue—breast cancer	0.000192	0.00578	CbGeAlD
Nifedipine—CYP2C8—female reproductive system—breast cancer	0.000191	0.00575	CbGeAlD
Nifedipine—CYP3A5—adipose tissue—breast cancer	0.000188	0.00565	CbGeAlD
Nifedipine—ABCC3—lymph node—breast cancer	0.000187	0.00561	CbGeAlD
Nifedipine—CYP1A1—female reproductive system—breast cancer	0.000176	0.00531	CbGeAlD
Nifedipine—CALM3—lymph node—breast cancer	0.000172	0.00517	CbGeAlD
Nifedipine—CYP2B6—female reproductive system—breast cancer	0.000171	0.00516	CbGeAlD
Nifedipine—CYP2C9—female reproductive system—breast cancer	0.00017	0.00511	CbGeAlD
Nifedipine—CYP2B6—adrenal gland—breast cancer	0.000167	0.00503	CbGeAlD
Nifedipine—CYP2C8—endocrine gland—breast cancer	0.000162	0.00487	CbGeAlD
Nifedipine—CYP2E1—female reproductive system—breast cancer	0.000161	0.00484	CbGeAlD
Nifedipine—CYP1A1—female gonad—breast cancer	0.000161	0.00483	CbGeAlD
Nifedipine—CYP2E1—adrenal gland—breast cancer	0.000157	0.00472	CbGeAlD
Nifedipine—CYP3A5—female gonad—breast cancer	0.000157	0.00472	CbGeAlD
Nifedipine—CYP1A2—endocrine gland—breast cancer	0.000151	0.00455	CbGeAlD
Nifedipine—ABCB1—embryo—breast cancer	0.000151	0.00455	CbGeAlD
Nifedipine—CYP1A1—endocrine gland—breast cancer	0.000149	0.00449	CbGeAlD
Nifedipine—ABCC2—lymph node—breast cancer	0.000149	0.00449	CbGeAlD
Nifedipine—CYP3A5—endocrine gland—breast cancer	0.000146	0.00439	CbGeAlD
Nifedipine—CYP2B6—endocrine gland—breast cancer	0.000145	0.00437	CbGeAlD
Nifedipine—CYP2C9—endocrine gland—breast cancer	0.000144	0.00432	CbGeAlD
Nifedipine—Lercanidipine—CYP2D6—breast cancer	0.000137	0.0569	CrCbGaD
Nifedipine—CYP2E1—endocrine gland—breast cancer	0.000136	0.0041	CbGeAlD
Nifedipine—CALM2—lymph node—breast cancer	0.000135	0.00406	CbGeAlD
Nifedipine—CALM1—lymph node—breast cancer	0.000134	0.00404	CbGeAlD
Nifedipine—CYP3A4—female reproductive system—breast cancer	0.000129	0.0039	CbGeAlD
Nifedipine—CYP2D6—female reproductive system—breast cancer	0.000127	0.00383	CbGeAlD
Nifedipine—ABCB1—epithelium—breast cancer	0.000123	0.00371	CbGeAlD
Nifedipine—Lercanidipine—CYP3A4—breast cancer	0.000117	0.0488	CrCbGaD
Nifedipine—CYP2D6—female gonad—breast cancer	0.000116	0.00349	CbGeAlD
Nifedipine—Amlodipine—CYP1A1—breast cancer	0.000113	0.047	CrCbGaD
Nifedipine—ABCB1—endometrium—breast cancer	0.000111	0.00333	CbGeAlD
Nifedipine—CYP3A4—endocrine gland—breast cancer	0.00011	0.0033	CbGeAlD
Nifedipine—Clevidipine—CYP2D6—breast cancer	0.000109	0.0453	CrCbGaD
Nifedipine—CYP2D6—endocrine gland—breast cancer	0.000108	0.00324	CbGeAlD
Nifedipine—Isradipine—CYP3A4—breast cancer	0.000106	0.0441	CrCbGaD
Nifedipine—CYP1A1—lymph node—breast cancer	0.000103	0.00311	CbGeAlD
Nifedipine—ABCB1—uterus—breast cancer	0.000102	0.00307	CbGeAlD
Nifedipine—ABCB1—pituitary gland—breast cancer	0.0001	0.00301	CbGeAlD
Nifedipine—ABCB1—adipose tissue—breast cancer	9.97e-05	0.003	CbGeAlD
Nifedipine—Clevidipine—CYP3A4—breast cancer	9.35e-05	0.0388	CrCbGaD
Nifedipine—ABCB1—female reproductive system—breast cancer	9.16e-05	0.00276	CbGeAlD
Nifedipine—Nisoldipine—CYP3A4—breast cancer	8.97e-05	0.0372	CrCbGaD
Nifedipine—ABCB1—adrenal gland—breast cancer	8.94e-05	0.00269	CbGeAlD
Nifedipine—Nimodipine—CYP3A4—breast cancer	8.66e-05	0.036	CrCbGaD
Nifedipine—ABCB1—bone marrow—breast cancer	8.65e-05	0.0026	CbGeAlD
Nifedipine—Amlodipine—CYP2D6—breast cancer	8.42e-05	0.035	CrCbGaD
Nifedipine—Nitrendipine—CYP3A4—breast cancer	8.39e-05	0.0348	CrCbGaD
Nifedipine—Nilvadipine—CYP3A4—breast cancer	8.39e-05	0.0348	CrCbGaD
Nifedipine—ABCB1—female gonad—breast cancer	8.34e-05	0.00251	CbGeAlD
Nifedipine—Felodipine—CYP2D6—breast cancer	7.78e-05	0.0323	CrCbGaD
Nifedipine—ABCB1—endocrine gland—breast cancer	7.76e-05	0.00233	CbGeAlD
Nifedipine—Nisoldipine—ABCB1—breast cancer	7.46e-05	0.031	CrCbGaD
Nifedipine—Nicardipine—CYP2D6—breast cancer	7.41e-05	0.0308	CrCbGaD
Nifedipine—Amlodipine—CYP3A4—breast cancer	7.22e-05	0.03	CrCbGaD
Nifedipine—Nitrendipine—ABCB1—breast cancer	6.98e-05	0.029	CrCbGaD
Nifedipine—Felodipine—CYP3A4—breast cancer	6.67e-05	0.0277	CrCbGaD
Nifedipine—Nicardipine—CYP3A4—breast cancer	6.36e-05	0.0264	CrCbGaD
Nifedipine—Amlodipine—ABCB1—breast cancer	6.01e-05	0.025	CrCbGaD
Nifedipine—Felodipine—ABCB1—breast cancer	5.56e-05	0.0231	CrCbGaD
Nifedipine—ABCB1—lymph node—breast cancer	5.36e-05	0.00161	CbGeAlD
Nifedipine—Nicardipine—ABCB1—breast cancer	5.29e-05	0.022	CrCbGaD
Nifedipine—Urinary tract disorder—Doxorubicin—breast cancer	2.13e-05	0.000136	CcSEcCtD
Nifedipine—Oedema peripheral—Doxorubicin—breast cancer	2.12e-05	0.000135	CcSEcCtD
Nifedipine—Dysgeusia—Methotrexate—breast cancer	2.12e-05	0.000135	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Docetaxel—breast cancer	2.12e-05	0.000135	CcSEcCtD
Nifedipine—Connective tissue disorder—Doxorubicin—breast cancer	2.11e-05	0.000135	CcSEcCtD
Nifedipine—Dyspnoea—Capecitabine—breast cancer	2.11e-05	0.000135	CcSEcCtD
Nifedipine—Fatigue—Docetaxel—breast cancer	2.11e-05	0.000135	CcSEcCtD
Nifedipine—Angiopathy—Epirubicin—breast cancer	2.11e-05	0.000135	CcSEcCtD
Nifedipine—Urethral disorder—Doxorubicin—breast cancer	2.11e-05	0.000135	CcSEcCtD
Nifedipine—Nausea—Mitoxantrone—breast cancer	2.11e-05	0.000134	CcSEcCtD
Nifedipine—Nausea—Irinotecan—breast cancer	2.11e-05	0.000134	CcSEcCtD
Nifedipine—Immune system disorder—Epirubicin—breast cancer	2.1e-05	0.000134	CcSEcCtD
Nifedipine—Mediastinal disorder—Epirubicin—breast cancer	2.1e-05	0.000134	CcSEcCtD
Nifedipine—Constipation—Docetaxel—breast cancer	2.1e-05	0.000134	CcSEcCtD
Nifedipine—Pain—Docetaxel—breast cancer	2.1e-05	0.000134	CcSEcCtD
Nifedipine—Back pain—Methotrexate—breast cancer	2.09e-05	0.000134	CcSEcCtD
Nifedipine—Dyspepsia—Capecitabine—breast cancer	2.09e-05	0.000133	CcSEcCtD
Nifedipine—Chills—Epirubicin—breast cancer	2.09e-05	0.000133	CcSEcCtD
Nifedipine—Arrhythmia—Epirubicin—breast cancer	2.08e-05	0.000133	CcSEcCtD
Nifedipine—Visual impairment—Doxorubicin—breast cancer	2.07e-05	0.000132	CcSEcCtD
Nifedipine—Asthenia—Paclitaxel—breast cancer	2.07e-05	0.000132	CcSEcCtD
Nifedipine—Decreased appetite—Capecitabine—breast cancer	2.06e-05	0.000132	CcSEcCtD
Nifedipine—Alopecia—Epirubicin—breast cancer	2.06e-05	0.000131	CcSEcCtD
Nifedipine—Nausea—Gemcitabine—breast cancer	2.05e-05	0.000131	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Capecitabine—breast cancer	2.05e-05	0.000131	CcSEcCtD
Nifedipine—Fatigue—Capecitabine—breast cancer	2.05e-05	0.000131	CcSEcCtD
Nifedipine—Pruritus—Paclitaxel—breast cancer	2.04e-05	0.000131	CcSEcCtD
Nifedipine—Vision blurred—Methotrexate—breast cancer	2.04e-05	0.00013	CcSEcCtD
Nifedipine—Mental disorder—Epirubicin—breast cancer	2.04e-05	0.00013	CcSEcCtD
Nifedipine—Erythema multiforme—Doxorubicin—breast cancer	2.03e-05	0.00013	CcSEcCtD
Nifedipine—Constipation—Capecitabine—breast cancer	2.03e-05	0.00013	CcSEcCtD
Nifedipine—Pain—Capecitabine—breast cancer	2.03e-05	0.00013	CcSEcCtD
Nifedipine—Erythema—Epirubicin—breast cancer	2.02e-05	0.000129	CcSEcCtD
Nifedipine—Malnutrition—Epirubicin—breast cancer	2.02e-05	0.000129	CcSEcCtD
Nifedipine—Feeling abnormal—Docetaxel—breast cancer	2.02e-05	0.000129	CcSEcCtD
Nifedipine—Nausea—Fluorouracil—breast cancer	2.02e-05	0.000129	CcSEcCtD
Nifedipine—Eye disorder—Doxorubicin—breast cancer	2.01e-05	0.000128	CcSEcCtD
Nifedipine—Ill-defined disorder—Methotrexate—breast cancer	2.01e-05	0.000128	CcSEcCtD
Nifedipine—Tinnitus—Doxorubicin—breast cancer	2.01e-05	0.000128	CcSEcCtD
Nifedipine—Gastrointestinal pain—Docetaxel—breast cancer	2e-05	0.000128	CcSEcCtD
Nifedipine—Anaemia—Methotrexate—breast cancer	2e-05	0.000128	CcSEcCtD
Nifedipine—Flushing—Doxorubicin—breast cancer	2e-05	0.000128	CcSEcCtD
Nifedipine—Cardiac disorder—Doxorubicin—breast cancer	2e-05	0.000128	CcSEcCtD
Nifedipine—Flatulence—Epirubicin—breast cancer	2e-05	0.000127	CcSEcCtD
Nifedipine—Tension—Epirubicin—breast cancer	1.99e-05	0.000127	CcSEcCtD
Nifedipine—Dysgeusia—Epirubicin—breast cancer	1.98e-05	0.000127	CcSEcCtD
Nifedipine—Diarrhoea—Paclitaxel—breast cancer	1.98e-05	0.000126	CcSEcCtD
Nifedipine—Nervousness—Epirubicin—breast cancer	1.97e-05	0.000126	CcSEcCtD
Nifedipine—Back pain—Epirubicin—breast cancer	1.96e-05	0.000125	CcSEcCtD
Nifedipine—Feeling abnormal—Capecitabine—breast cancer	1.95e-05	0.000125	CcSEcCtD
Nifedipine—Angiopathy—Doxorubicin—breast cancer	1.95e-05	0.000125	CcSEcCtD
Nifedipine—Malaise—Methotrexate—breast cancer	1.95e-05	0.000125	CcSEcCtD
Nifedipine—Muscle spasms—Epirubicin—breast cancer	1.95e-05	0.000124	CcSEcCtD
Nifedipine—Immune system disorder—Doxorubicin—breast cancer	1.94e-05	0.000124	CcSEcCtD
Nifedipine—Vertigo—Methotrexate—breast cancer	1.94e-05	0.000124	CcSEcCtD
Nifedipine—Gastrointestinal pain—Capecitabine—breast cancer	1.94e-05	0.000124	CcSEcCtD
Nifedipine—Mediastinal disorder—Doxorubicin—breast cancer	1.94e-05	0.000124	CcSEcCtD
Nifedipine—Abdominal pain—Docetaxel—breast cancer	1.94e-05	0.000124	CcSEcCtD
Nifedipine—Body temperature increased—Docetaxel—breast cancer	1.94e-05	0.000124	CcSEcCtD
Nifedipine—Leukopenia—Methotrexate—breast cancer	1.94e-05	0.000124	CcSEcCtD
Nifedipine—Chills—Doxorubicin—breast cancer	1.93e-05	0.000123	CcSEcCtD
Nifedipine—Arrhythmia—Doxorubicin—breast cancer	1.92e-05	0.000123	CcSEcCtD
Nifedipine—Dizziness—Paclitaxel—breast cancer	1.91e-05	0.000122	CcSEcCtD
Nifedipine—Vision blurred—Epirubicin—breast cancer	1.91e-05	0.000122	CcSEcCtD
Nifedipine—Alopecia—Doxorubicin—breast cancer	1.9e-05	0.000121	CcSEcCtD
Nifedipine—Cough—Methotrexate—breast cancer	1.89e-05	0.000121	CcSEcCtD
Nifedipine—Mental disorder—Doxorubicin—breast cancer	1.89e-05	0.00012	CcSEcCtD
Nifedipine—Urticaria—Capecitabine—breast cancer	1.88e-05	0.00012	CcSEcCtD
Nifedipine—Ill-defined disorder—Epirubicin—breast cancer	1.88e-05	0.00012	CcSEcCtD
Nifedipine—Abdominal pain—Capecitabine—breast cancer	1.88e-05	0.00012	CcSEcCtD
Nifedipine—Body temperature increased—Capecitabine—breast cancer	1.88e-05	0.00012	CcSEcCtD
Nifedipine—Erythema—Doxorubicin—breast cancer	1.87e-05	0.00012	CcSEcCtD
Nifedipine—Malnutrition—Doxorubicin—breast cancer	1.87e-05	0.00012	CcSEcCtD
Nifedipine—Anaemia—Epirubicin—breast cancer	1.87e-05	0.00012	CcSEcCtD
Nifedipine—Agitation—Epirubicin—breast cancer	1.86e-05	0.000119	CcSEcCtD
Nifedipine—Flatulence—Doxorubicin—breast cancer	1.85e-05	0.000118	CcSEcCtD
Nifedipine—Myalgia—Methotrexate—breast cancer	1.84e-05	0.000118	CcSEcCtD
Nifedipine—Chest pain—Methotrexate—breast cancer	1.84e-05	0.000118	CcSEcCtD
Nifedipine—Arthralgia—Methotrexate—breast cancer	1.84e-05	0.000118	CcSEcCtD
Nifedipine—Tension—Doxorubicin—breast cancer	1.84e-05	0.000117	CcSEcCtD
Nifedipine—Vomiting—Paclitaxel—breast cancer	1.84e-05	0.000117	CcSEcCtD
Nifedipine—Dysgeusia—Doxorubicin—breast cancer	1.83e-05	0.000117	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.83e-05	0.000117	CcSEcCtD
Nifedipine—Malaise—Epirubicin—breast cancer	1.83e-05	0.000117	CcSEcCtD
Nifedipine—Rash—Paclitaxel—breast cancer	1.82e-05	0.000116	CcSEcCtD
Nifedipine—Dermatitis—Paclitaxel—breast cancer	1.82e-05	0.000116	CcSEcCtD
Nifedipine—Discomfort—Methotrexate—breast cancer	1.82e-05	0.000116	CcSEcCtD
Nifedipine—Nervousness—Doxorubicin—breast cancer	1.82e-05	0.000116	CcSEcCtD
Nifedipine—Vertigo—Epirubicin—breast cancer	1.82e-05	0.000116	CcSEcCtD
Nifedipine—Syncope—Epirubicin—breast cancer	1.82e-05	0.000116	CcSEcCtD
Nifedipine—Leukopenia—Epirubicin—breast cancer	1.81e-05	0.000116	CcSEcCtD
Nifedipine—Back pain—Doxorubicin—breast cancer	1.81e-05	0.000116	CcSEcCtD
Nifedipine—Headache—Paclitaxel—breast cancer	1.81e-05	0.000116	CcSEcCtD
Nifedipine—Hypersensitivity—Docetaxel—breast cancer	1.81e-05	0.000115	CcSEcCtD
Nifedipine—Muscle spasms—Doxorubicin—breast cancer	1.8e-05	0.000115	CcSEcCtD
Nifedipine—Palpitations—Epirubicin—breast cancer	1.79e-05	0.000114	CcSEcCtD
Nifedipine—Confusional state—Methotrexate—breast cancer	1.78e-05	0.000114	CcSEcCtD
Nifedipine—Loss of consciousness—Epirubicin—breast cancer	1.78e-05	0.000114	CcSEcCtD
Nifedipine—Cough—Epirubicin—breast cancer	1.77e-05	0.000113	CcSEcCtD
Nifedipine—Anaphylactic shock—Methotrexate—breast cancer	1.77e-05	0.000113	CcSEcCtD
Nifedipine—Vision blurred—Doxorubicin—breast cancer	1.77e-05	0.000113	CcSEcCtD
Nifedipine—Asthenia—Docetaxel—breast cancer	1.76e-05	0.000112	CcSEcCtD
Nifedipine—Hypersensitivity—Capecitabine—breast cancer	1.75e-05	0.000112	CcSEcCtD
Nifedipine—Ill-defined disorder—Doxorubicin—breast cancer	1.74e-05	0.000111	CcSEcCtD
Nifedipine—Pruritus—Docetaxel—breast cancer	1.73e-05	0.000111	CcSEcCtD
Nifedipine—Nervous system disorder—Methotrexate—breast cancer	1.73e-05	0.000111	CcSEcCtD
Nifedipine—Anaemia—Doxorubicin—breast cancer	1.73e-05	0.000111	CcSEcCtD
Nifedipine—Thrombocytopenia—Methotrexate—breast cancer	1.73e-05	0.00011	CcSEcCtD
Nifedipine—Myalgia—Epirubicin—breast cancer	1.72e-05	0.00011	CcSEcCtD
Nifedipine—Chest pain—Epirubicin—breast cancer	1.72e-05	0.00011	CcSEcCtD
Nifedipine—Arthralgia—Epirubicin—breast cancer	1.72e-05	0.00011	CcSEcCtD
Nifedipine—Agitation—Doxorubicin—breast cancer	1.72e-05	0.00011	CcSEcCtD
Nifedipine—Anxiety—Epirubicin—breast cancer	1.72e-05	0.00011	CcSEcCtD
Nifedipine—Nausea—Paclitaxel—breast cancer	1.72e-05	0.00011	CcSEcCtD
Nifedipine—Skin disorder—Methotrexate—breast cancer	1.72e-05	0.00011	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.71e-05	0.000109	CcSEcCtD
Nifedipine—Hyperhidrosis—Methotrexate—breast cancer	1.71e-05	0.000109	CcSEcCtD
Nifedipine—Discomfort—Epirubicin—breast cancer	1.7e-05	0.000109	CcSEcCtD
Nifedipine—Asthenia—Capecitabine—breast cancer	1.7e-05	0.000109	CcSEcCtD
Nifedipine—Malaise—Doxorubicin—breast cancer	1.69e-05	0.000108	CcSEcCtD
Nifedipine—Dry mouth—Epirubicin—breast cancer	1.69e-05	0.000108	CcSEcCtD
Nifedipine—Vertigo—Doxorubicin—breast cancer	1.68e-05	0.000108	CcSEcCtD
Nifedipine—Anorexia—Methotrexate—breast cancer	1.68e-05	0.000108	CcSEcCtD
Nifedipine—Syncope—Doxorubicin—breast cancer	1.68e-05	0.000107	CcSEcCtD
Nifedipine—Pruritus—Capecitabine—breast cancer	1.68e-05	0.000107	CcSEcCtD
Nifedipine—Leukopenia—Doxorubicin—breast cancer	1.68e-05	0.000107	CcSEcCtD
Nifedipine—Diarrhoea—Docetaxel—breast cancer	1.68e-05	0.000107	CcSEcCtD
Nifedipine—Confusional state—Epirubicin—breast cancer	1.67e-05	0.000106	CcSEcCtD
Nifedipine—Palpitations—Doxorubicin—breast cancer	1.66e-05	0.000106	CcSEcCtD
Nifedipine—Oedema—Epirubicin—breast cancer	1.65e-05	0.000106	CcSEcCtD
Nifedipine—Anaphylactic shock—Epirubicin—breast cancer	1.65e-05	0.000106	CcSEcCtD
Nifedipine—Hypotension—Methotrexate—breast cancer	1.65e-05	0.000105	CcSEcCtD
Nifedipine—Loss of consciousness—Doxorubicin—breast cancer	1.65e-05	0.000105	CcSEcCtD
Nifedipine—Cough—Doxorubicin—breast cancer	1.63e-05	0.000104	CcSEcCtD
Nifedipine—Shock—Epirubicin—breast cancer	1.63e-05	0.000104	CcSEcCtD
Nifedipine—Diarrhoea—Capecitabine—breast cancer	1.62e-05	0.000104	CcSEcCtD
Nifedipine—Nervous system disorder—Epirubicin—breast cancer	1.62e-05	0.000104	CcSEcCtD
Nifedipine—Dizziness—Docetaxel—breast cancer	1.62e-05	0.000103	CcSEcCtD
Nifedipine—Thrombocytopenia—Epirubicin—breast cancer	1.62e-05	0.000103	CcSEcCtD
Nifedipine—Tachycardia—Epirubicin—breast cancer	1.61e-05	0.000103	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Methotrexate—breast cancer	1.61e-05	0.000103	CcSEcCtD
Nifedipine—Skin disorder—Epirubicin—breast cancer	1.61e-05	0.000103	CcSEcCtD
Nifedipine—Hyperhidrosis—Epirubicin—breast cancer	1.6e-05	0.000102	CcSEcCtD
Nifedipine—Insomnia—Methotrexate—breast cancer	1.6e-05	0.000102	CcSEcCtD
Nifedipine—Arthralgia—Doxorubicin—breast cancer	1.59e-05	0.000102	CcSEcCtD
Nifedipine—Chest pain—Doxorubicin—breast cancer	1.59e-05	0.000102	CcSEcCtD
Nifedipine—Myalgia—Doxorubicin—breast cancer	1.59e-05	0.000102	CcSEcCtD
Nifedipine—Anxiety—Doxorubicin—breast cancer	1.59e-05	0.000102	CcSEcCtD
Nifedipine—Paraesthesia—Methotrexate—breast cancer	1.59e-05	0.000101	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.58e-05	0.000101	CcSEcCtD
Nifedipine—Discomfort—Doxorubicin—breast cancer	1.58e-05	0.000101	CcSEcCtD
Nifedipine—Anorexia—Epirubicin—breast cancer	1.58e-05	0.000101	CcSEcCtD
Nifedipine—Dyspnoea—Methotrexate—breast cancer	1.57e-05	0.000101	CcSEcCtD
Nifedipine—Somnolence—Methotrexate—breast cancer	1.57e-05	0.0001	CcSEcCtD
Nifedipine—Dizziness—Capecitabine—breast cancer	1.57e-05	0.0001	CcSEcCtD
Nifedipine—Dry mouth—Doxorubicin—breast cancer	1.56e-05	9.97e-05	CcSEcCtD
Nifedipine—Vomiting—Docetaxel—breast cancer	1.56e-05	9.95e-05	CcSEcCtD
Nifedipine—Dyspepsia—Methotrexate—breast cancer	1.55e-05	9.93e-05	CcSEcCtD
Nifedipine—Rash—Docetaxel—breast cancer	1.54e-05	9.87e-05	CcSEcCtD
Nifedipine—Hypotension—Epirubicin—breast cancer	1.54e-05	9.86e-05	CcSEcCtD
Nifedipine—Dermatitis—Docetaxel—breast cancer	1.54e-05	9.86e-05	CcSEcCtD
Nifedipine—Confusional state—Doxorubicin—breast cancer	1.54e-05	9.85e-05	CcSEcCtD
Nifedipine—Decreased appetite—Methotrexate—breast cancer	1.53e-05	9.81e-05	CcSEcCtD
Nifedipine—Headache—Docetaxel—breast cancer	1.53e-05	9.81e-05	CcSEcCtD
Nifedipine—Oedema—Doxorubicin—breast cancer	1.53e-05	9.77e-05	CcSEcCtD
Nifedipine—Anaphylactic shock—Doxorubicin—breast cancer	1.53e-05	9.77e-05	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Methotrexate—breast cancer	1.52e-05	9.74e-05	CcSEcCtD
Nifedipine—Fatigue—Methotrexate—breast cancer	1.52e-05	9.73e-05	CcSEcCtD
Nifedipine—Pain—Methotrexate—breast cancer	1.51e-05	9.65e-05	CcSEcCtD
Nifedipine—Vomiting—Capecitabine—breast cancer	1.51e-05	9.63e-05	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Epirubicin—breast cancer	1.51e-05	9.62e-05	CcSEcCtD
Nifedipine—Shock—Doxorubicin—breast cancer	1.5e-05	9.61e-05	CcSEcCtD
Nifedipine—Nervous system disorder—Doxorubicin—breast cancer	1.5e-05	9.58e-05	CcSEcCtD
Nifedipine—Thrombocytopenia—Doxorubicin—breast cancer	1.5e-05	9.56e-05	CcSEcCtD
Nifedipine—Rash—Capecitabine—breast cancer	1.5e-05	9.55e-05	CcSEcCtD
Nifedipine—Insomnia—Epirubicin—breast cancer	1.49e-05	9.55e-05	CcSEcCtD
Nifedipine—Dermatitis—Capecitabine—breast cancer	1.49e-05	9.55e-05	CcSEcCtD
Nifedipine—Tachycardia—Doxorubicin—breast cancer	1.49e-05	9.53e-05	CcSEcCtD
Nifedipine—Headache—Capecitabine—breast cancer	1.49e-05	9.49e-05	CcSEcCtD
Nifedipine—Skin disorder—Doxorubicin—breast cancer	1.49e-05	9.49e-05	CcSEcCtD
Nifedipine—Paraesthesia—Epirubicin—breast cancer	1.48e-05	9.48e-05	CcSEcCtD
Nifedipine—Hyperhidrosis—Doxorubicin—breast cancer	1.48e-05	9.44e-05	CcSEcCtD
Nifedipine—Dyspnoea—Epirubicin—breast cancer	1.47e-05	9.41e-05	CcSEcCtD
Nifedipine—Somnolence—Epirubicin—breast cancer	1.47e-05	9.39e-05	CcSEcCtD
Nifedipine—Anorexia—Doxorubicin—breast cancer	1.46e-05	9.31e-05	CcSEcCtD
Nifedipine—Nausea—Docetaxel—breast cancer	1.46e-05	9.3e-05	CcSEcCtD
Nifedipine—Feeling abnormal—Methotrexate—breast cancer	1.46e-05	9.3e-05	CcSEcCtD
Nifedipine—Dyspepsia—Epirubicin—breast cancer	1.45e-05	9.29e-05	CcSEcCtD
Nifedipine—Gastrointestinal pain—Methotrexate—breast cancer	1.44e-05	9.22e-05	CcSEcCtD
Nifedipine—Decreased appetite—Epirubicin—breast cancer	1.44e-05	9.18e-05	CcSEcCtD
Nifedipine—Hypotension—Doxorubicin—breast cancer	1.43e-05	9.13e-05	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Epirubicin—breast cancer	1.43e-05	9.11e-05	CcSEcCtD
Nifedipine—Fatigue—Epirubicin—breast cancer	1.42e-05	9.1e-05	CcSEcCtD
Nifedipine—Pain—Epirubicin—breast cancer	1.41e-05	9.03e-05	CcSEcCtD
Nifedipine—Constipation—Epirubicin—breast cancer	1.41e-05	9.03e-05	CcSEcCtD
Nifedipine—Nausea—Capecitabine—breast cancer	1.41e-05	9e-05	CcSEcCtD
Nifedipine—Urticaria—Methotrexate—breast cancer	1.4e-05	8.96e-05	CcSEcCtD
Nifedipine—Abdominal pain—Methotrexate—breast cancer	1.4e-05	8.92e-05	CcSEcCtD
Nifedipine—Body temperature increased—Methotrexate—breast cancer	1.4e-05	8.92e-05	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.39e-05	8.9e-05	CcSEcCtD
Nifedipine—Insomnia—Doxorubicin—breast cancer	1.38e-05	8.83e-05	CcSEcCtD
Nifedipine—Paraesthesia—Doxorubicin—breast cancer	1.37e-05	8.77e-05	CcSEcCtD
Nifedipine—Dyspnoea—Doxorubicin—breast cancer	1.36e-05	8.71e-05	CcSEcCtD
Nifedipine—Feeling abnormal—Epirubicin—breast cancer	1.36e-05	8.7e-05	CcSEcCtD
Nifedipine—Somnolence—Doxorubicin—breast cancer	1.36e-05	8.68e-05	CcSEcCtD
Nifedipine—Gastrointestinal pain—Epirubicin—breast cancer	1.35e-05	8.63e-05	CcSEcCtD
Nifedipine—Dyspepsia—Doxorubicin—breast cancer	1.35e-05	8.6e-05	CcSEcCtD
Nifedipine—Decreased appetite—Doxorubicin—breast cancer	1.33e-05	8.49e-05	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Doxorubicin—breast cancer	1.32e-05	8.43e-05	CcSEcCtD
Nifedipine—Fatigue—Doxorubicin—breast cancer	1.32e-05	8.42e-05	CcSEcCtD
Nifedipine—Urticaria—Epirubicin—breast cancer	1.31e-05	8.39e-05	CcSEcCtD
Nifedipine—Constipation—Doxorubicin—breast cancer	1.31e-05	8.35e-05	CcSEcCtD
Nifedipine—Pain—Doxorubicin—breast cancer	1.31e-05	8.35e-05	CcSEcCtD
Nifedipine—Abdominal pain—Epirubicin—breast cancer	1.31e-05	8.35e-05	CcSEcCtD
Nifedipine—Body temperature increased—Epirubicin—breast cancer	1.31e-05	8.35e-05	CcSEcCtD
Nifedipine—Hypersensitivity—Methotrexate—breast cancer	1.3e-05	8.31e-05	CcSEcCtD
Nifedipine—Asthenia—Methotrexate—breast cancer	1.27e-05	8.09e-05	CcSEcCtD
Nifedipine—Feeling abnormal—Doxorubicin—breast cancer	1.26e-05	8.05e-05	CcSEcCtD
Nifedipine—Gastrointestinal pain—Doxorubicin—breast cancer	1.25e-05	7.99e-05	CcSEcCtD
Nifedipine—Pruritus—Methotrexate—breast cancer	1.25e-05	7.98e-05	CcSEcCtD
Nifedipine—Hypersensitivity—Epirubicin—breast cancer	1.22e-05	7.78e-05	CcSEcCtD
Nifedipine—Urticaria—Doxorubicin—breast cancer	1.21e-05	7.76e-05	CcSEcCtD
Nifedipine—Abdominal pain—Doxorubicin—breast cancer	1.21e-05	7.72e-05	CcSEcCtD
Nifedipine—Body temperature increased—Doxorubicin—breast cancer	1.21e-05	7.72e-05	CcSEcCtD
Nifedipine—Diarrhoea—Methotrexate—breast cancer	1.21e-05	7.72e-05	CcSEcCtD
Nifedipine—Asthenia—Epirubicin—breast cancer	1.19e-05	7.57e-05	CcSEcCtD
Nifedipine—Pruritus—Epirubicin—breast cancer	1.17e-05	7.47e-05	CcSEcCtD
Nifedipine—Dizziness—Methotrexate—breast cancer	1.17e-05	7.46e-05	CcSEcCtD
Nifedipine—Diarrhoea—Epirubicin—breast cancer	1.13e-05	7.22e-05	CcSEcCtD
Nifedipine—Hypersensitivity—Doxorubicin—breast cancer	1.13e-05	7.2e-05	CcSEcCtD
Nifedipine—Vomiting—Methotrexate—breast cancer	1.12e-05	7.17e-05	CcSEcCtD
Nifedipine—Rash—Methotrexate—breast cancer	1.11e-05	7.11e-05	CcSEcCtD
Nifedipine—Dermatitis—Methotrexate—breast cancer	1.11e-05	7.11e-05	CcSEcCtD
Nifedipine—Headache—Methotrexate—breast cancer	1.11e-05	7.07e-05	CcSEcCtD
Nifedipine—Asthenia—Doxorubicin—breast cancer	1.1e-05	7.01e-05	CcSEcCtD
Nifedipine—Dizziness—Epirubicin—breast cancer	1.09e-05	6.98e-05	CcSEcCtD
Nifedipine—Pruritus—Doxorubicin—breast cancer	1.08e-05	6.91e-05	CcSEcCtD
Nifedipine—Vomiting—Epirubicin—breast cancer	1.05e-05	6.71e-05	CcSEcCtD
Nifedipine—Nausea—Methotrexate—breast cancer	1.05e-05	6.7e-05	CcSEcCtD
Nifedipine—Diarrhoea—Doxorubicin—breast cancer	1.05e-05	6.68e-05	CcSEcCtD
Nifedipine—Rash—Epirubicin—breast cancer	1.04e-05	6.66e-05	CcSEcCtD
Nifedipine—Dermatitis—Epirubicin—breast cancer	1.04e-05	6.65e-05	CcSEcCtD
Nifedipine—Headache—Epirubicin—breast cancer	1.04e-05	6.61e-05	CcSEcCtD
Nifedipine—Dizziness—Doxorubicin—breast cancer	1.01e-05	6.46e-05	CcSEcCtD
Nifedipine—Nausea—Epirubicin—breast cancer	9.82e-06	6.27e-05	CcSEcCtD
Nifedipine—Vomiting—Doxorubicin—breast cancer	9.72e-06	6.21e-05	CcSEcCtD
Nifedipine—Rash—Doxorubicin—breast cancer	9.64e-06	6.16e-05	CcSEcCtD
Nifedipine—Dermatitis—Doxorubicin—breast cancer	9.63e-06	6.15e-05	CcSEcCtD
Nifedipine—Headache—Doxorubicin—breast cancer	9.58e-06	6.12e-05	CcSEcCtD
Nifedipine—Nausea—Doxorubicin—breast cancer	9.08e-06	5.8e-05	CcSEcCtD
Nifedipine—CALM2—Disease—SRC—breast cancer	7.69e-07	6.78e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—SRC—breast cancer	7.69e-07	6.78e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CG—breast cancer	7.67e-07	6.77e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—MAPK3—breast cancer	7.67e-07	6.77e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—MAPK3—breast cancer	7.67e-07	6.77e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—STAT3—breast cancer	7.66e-07	6.76e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SERPINE1—breast cancer	7.62e-07	6.72e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SERPINE1—breast cancer	7.62e-07	6.72e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—KRAS—breast cancer	7.54e-07	6.66e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—KRAS—breast cancer	7.54e-07	6.66e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—EGFR—breast cancer	7.54e-07	6.65e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NOS3—breast cancer	7.52e-07	6.64e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—COMT—breast cancer	7.45e-07	6.57e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTP1—breast cancer	7.41e-07	6.54e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—STAT3—breast cancer	7.41e-07	6.54e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—STAT3—breast cancer	7.41e-07	6.54e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTEN—breast cancer	7.37e-07	6.5e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—MAPK3—breast cancer	7.32e-07	6.46e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—HMOX1—breast cancer	7.31e-07	6.45e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—EGFR—breast cancer	7.3e-07	6.44e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—EGFR—breast cancer	7.3e-07	6.44e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ITPR1—breast cancer	7.3e-07	6.44e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NOS3—breast cancer	7.28e-07	6.42e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NOS3—breast cancer	7.28e-07	6.42e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CB—breast cancer	7.22e-07	6.37e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTEN—breast cancer	7.22e-07	6.37e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CD—breast cancer	7.22e-07	6.37e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTEN—breast cancer	7.21e-07	6.36e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CAV1—breast cancer	7.2e-07	6.35e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTEN—breast cancer	7.17e-07	6.33e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—PIK3CA—breast cancer	7.16e-07	6.32e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTGS2—breast cancer	7.16e-07	6.31e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MDM2—breast cancer	7.14e-07	6.3e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—ALB—breast cancer	7.13e-07	6.29e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KRAS—breast cancer	7.12e-07	6.29e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—MYC—breast cancer	7.12e-07	6.28e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—RAF1—breast cancer	7.11e-07	6.27e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—TGFB1—breast cancer	7.1e-07	6.27e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—MAPK3—breast cancer	7.08e-07	6.25e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—MAPK3—breast cancer	7.08e-07	6.25e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—RELA—breast cancer	7.08e-07	6.25e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—ERBB2—breast cancer	7.04e-07	6.21e-06	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PIK3CA—breast cancer	7.03e-07	6.2e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ABCB1—breast cancer	7.02e-07	6.19e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—EGFR—breast cancer	6.96e-07	6.14e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MTOR—breast cancer	6.94e-07	6.13e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CB—breast cancer	6.94e-07	6.13e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTEN—breast cancer	6.94e-07	6.12e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTEN—breast cancer	6.94e-07	6.12e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—PIK3CA—breast cancer	6.93e-07	6.11e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—PIK3CA—breast cancer	6.93e-07	6.11e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MDM2—breast cancer	6.9e-07	6.09e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MDM2—breast cancer	6.9e-07	6.09e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—TYMS—breast cancer	6.89e-07	6.08e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KRAS—breast cancer	6.89e-07	6.08e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KRAS—breast cancer	6.89e-07	6.08e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—MYC—breast cancer	6.89e-07	6.08e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—MYC—breast cancer	6.89e-07	6.08e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—RAF1—breast cancer	6.88e-07	6.07e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—RAF1—breast cancer	6.88e-07	6.07e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.88e-07	6.07e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—TGFB1—breast cancer	6.87e-07	6.06e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—TGFB1—breast cancer	6.87e-07	6.06e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—RELA—breast cancer	6.85e-07	6.04e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—RELA—breast cancer	6.85e-07	6.04e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—NOS3—breast cancer	6.82e-07	6.01e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PLA2G4A—breast cancer	6.81e-07	6.01e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTM1—breast cancer	6.81e-07	6.01e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—NCOR1—breast cancer	6.81e-07	6.01e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTEN—breast cancer	6.81e-07	6.01e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—ERBB2—breast cancer	6.81e-07	6e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—ERBB2—breast cancer	6.81e-07	6e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CD—breast cancer	6.8e-07	6e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CD—breast cancer	6.74e-07	5.95e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—EGFR—breast cancer	6.74e-07	5.94e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—EGFR—breast cancer	6.74e-07	5.94e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CB—breast cancer	6.72e-07	5.93e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MTOR—breast cancer	6.72e-07	5.93e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MTOR—breast cancer	6.72e-07	5.93e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CB—breast cancer	6.72e-07	5.93e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—ALB—breast cancer	6.72e-07	5.93e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CXCL8—breast cancer	6.67e-07	5.89e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—ALB—breast cancer	6.66e-07	5.87e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—HRAS—breast cancer	6.63e-07	5.85e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—KRAS—breast cancer	6.58e-07	5.8e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CG—breast cancer	6.56e-07	5.78e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—PIK3CA—breast cancer	6.55e-07	5.78e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GPX1—breast cancer	6.52e-07	5.76e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1B—breast cancer	6.52e-07	5.75e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP1A1—breast cancer	6.46e-07	5.7e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CXCL8—breast cancer	6.45e-07	5.69e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CXCL8—breast cancer	6.45e-07	5.69e-06	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PIK3CA—breast cancer	6.45e-07	5.69e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—NOS3—breast cancer	6.42e-07	5.67e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—HRAS—breast cancer	6.41e-07	5.66e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—HRAS—breast cancer	6.41e-07	5.66e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ERCC2—breast cancer	6.41e-07	5.65e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CASP3—breast cancer	6.39e-07	5.63e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL2—breast cancer	6.38e-07	5.63e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—NOS3—breast cancer	6.37e-07	5.62e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—KRAS—breast cancer	6.36e-07	5.61e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—KRAS—breast cancer	6.36e-07	5.61e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—IL6—breast cancer	6.34e-07	5.6e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—PIK3CA—breast cancer	6.33e-07	5.59e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—PIK3CA—breast cancer	6.33e-07	5.59e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1B—breast cancer	6.3e-07	5.56e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1B—breast cancer	6.3e-07	5.56e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CB—breast cancer	6.29e-07	5.55e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTEN—breast cancer	6.24e-07	5.51e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTGS2—breast cancer	6.23e-07	5.5e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCND1—breast cancer	6.22e-07	5.48e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—JUN—breast cancer	6.2e-07	5.47e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CASP3—breast cancer	6.18e-07	5.45e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CASP3—breast cancer	6.18e-07	5.45e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL2—breast cancer	6.17e-07	5.44e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL2—breast cancer	6.17e-07	5.44e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CTNNB1—breast cancer	6.16e-07	5.43e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—IL6—breast cancer	6.14e-07	5.41e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—IL6—breast cancer	6.14e-07	5.41e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HRAS—breast cancer	6.06e-07	5.34e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—PIK3CA—breast cancer	6.04e-07	5.33e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MMP9—breast cancer	6.03e-07	5.32e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—MTHFR—breast cancer	6.02e-07	5.31e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1A—breast cancer	6.01e-07	5.31e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCND1—breast cancer	6.01e-07	5.3e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCND1—breast cancer	6.01e-07	5.3e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—JUN—breast cancer	6e-07	5.29e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—JUN—breast cancer	6e-07	5.29e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PTEN—breast cancer	6e-07	5.29e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CTNNB1—breast cancer	5.95e-07	5.25e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CTNNB1—breast cancer	5.95e-07	5.25e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CB—breast cancer	5.93e-07	5.23e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CB—breast cancer	5.88e-07	5.19e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTGS2—breast cancer	5.88e-07	5.18e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MAPK8—breast cancer	5.87e-07	5.18e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HRAS—breast cancer	5.86e-07	5.17e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HRAS—breast cancer	5.86e-07	5.17e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—AKT1—breast cancer	5.85e-07	5.16e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—PIK3CA—breast cancer	5.85e-07	5.16e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—PIK3CA—breast cancer	5.85e-07	5.16e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MMP9—breast cancer	5.84e-07	5.15e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MMP9—breast cancer	5.84e-07	5.15e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTGS2—breast cancer	5.82e-07	5.14e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1A—breast cancer	5.82e-07	5.13e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1A—breast cancer	5.82e-07	5.13e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PTEN—breast cancer	5.8e-07	5.12e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PTEN—breast cancer	5.8e-07	5.12e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL6—breast cancer	5.8e-07	5.11e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CD—breast cancer	5.76e-07	5.08e-06	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—AKT1—breast cancer	5.74e-07	5.07e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ALB—breast cancer	5.69e-07	5.02e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAPK8—breast cancer	5.68e-07	5.01e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAPK8—breast cancer	5.68e-07	5.01e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—AKT1—breast cancer	5.66e-07	5e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—AKT1—breast cancer	5.66e-07	5e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL6—breast cancer	5.61e-07	4.95e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL6—breast cancer	5.61e-07	4.95e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—HRAS—breast cancer	5.59e-07	4.93e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SRC—breast cancer	5.56e-07	4.91e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CAV1—breast cancer	5.55e-07	4.9e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—NOS3—breast cancer	5.44e-07	4.8e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTEN—breast cancer	5.44e-07	4.8e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—breast cancer	5.42e-07	4.78e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—HRAS—breast cancer	5.41e-07	4.77e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—HRAS—breast cancer	5.41e-07	4.77e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SRC—breast cancer	5.38e-07	4.75e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SRC—breast cancer	5.38e-07	4.75e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—STAT3—breast cancer	5.37e-07	4.73e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—IL6—breast cancer	5.35e-07	4.72e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—AKT1—breast cancer	5.35e-07	4.72e-06	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—AKT1—breast cancer	5.27e-07	4.65e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—breast cancer	5.24e-07	4.62e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—breast cancer	5.24e-07	4.62e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3CA—breast cancer	5.2e-07	4.59e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—STAT3—breast cancer	5.19e-07	4.58e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—STAT3—breast cancer	5.19e-07	4.58e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—IL6—breast cancer	5.18e-07	4.57e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—IL6—breast cancer	5.18e-07	4.57e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—AKT1—breast cancer	5.17e-07	4.56e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—AKT1—breast cancer	5.17e-07	4.56e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MAPK3—breast cancer	5.13e-07	4.52e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTEN—breast cancer	5.12e-07	4.52e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3CA—breast cancer	5.09e-07	4.49e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3CA—breast cancer	5.08e-07	4.49e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTEN—breast cancer	5.08e-07	4.48e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3CA—breast cancer	5.06e-07	4.47e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CG—breast cancer	5.06e-07	4.46e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CB—breast cancer	5.02e-07	4.43e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MYC—breast cancer	4.99e-07	4.4e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTGS2—breast cancer	4.98e-07	4.39e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TGFB1—breast cancer	4.97e-07	4.39e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAPK3—breast cancer	4.96e-07	4.37e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAPK3—breast cancer	4.96e-07	4.37e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—AKT1—breast cancer	4.94e-07	4.36e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3CA—breast cancer	4.9e-07	4.32e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3CA—breast cancer	4.9e-07	4.32e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EGFR—breast cancer	4.88e-07	4.3e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MYC—breast cancer	4.82e-07	4.26e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MYC—breast cancer	4.82e-07	4.26e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TGFB1—breast cancer	4.81e-07	4.24e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TGFB1—breast cancer	4.81e-07	4.24e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CA—breast cancer	4.8e-07	4.24e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—AKT1—breast cancer	4.78e-07	4.21e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—AKT1—breast cancer	4.78e-07	4.21e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EGFR—breast cancer	4.72e-07	4.16e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EGFR—breast cancer	4.72e-07	4.16e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KRAS—breast cancer	4.61e-07	4.06e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KRAS—breast cancer	4.46e-07	3.93e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KRAS—breast cancer	4.46e-07	3.93e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CD—breast cancer	4.45e-07	3.92e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CA—breast cancer	4.4e-07	3.88e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ALB—breast cancer	4.39e-07	3.87e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTEN—breast cancer	4.34e-07	3.83e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—AKT1—breast cancer	4.25e-07	3.75e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CA—breast cancer	4.23e-07	3.73e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—NOS3—breast cancer	4.2e-07	3.71e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—AKT1—breast cancer	4.16e-07	3.67e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—AKT1—breast cancer	4.15e-07	3.66e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—AKT1—breast cancer	4.13e-07	3.65e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—breast cancer	4.09e-07	3.61e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CA—breast cancer	4.09e-07	3.61e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CA—breast cancer	4.09e-07	3.61e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—AKT1—breast cancer	4e-07	3.53e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—AKT1—breast cancer	4e-07	3.53e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—breast cancer	3.96e-07	3.49e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—breast cancer	3.96e-07	3.49e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—AKT1—breast cancer	3.92e-07	3.46e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—HRAS—breast cancer	3.92e-07	3.45e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CB—breast cancer	3.88e-07	3.42e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS2—breast cancer	3.84e-07	3.39e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CA—breast cancer	3.84e-07	3.38e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—HRAS—breast cancer	3.79e-07	3.34e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—HRAS—breast cancer	3.79e-07	3.34e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL6—breast cancer	3.75e-07	3.31e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL6—breast cancer	3.63e-07	3.2e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL6—breast cancer	3.63e-07	3.2e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CA—breast cancer	3.61e-07	3.19e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—AKT1—breast cancer	3.6e-07	3.17e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CA—breast cancer	3.58e-07	3.16e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—AKT1—breast cancer	3.46e-07	3.05e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTEN—breast cancer	3.35e-07	2.96e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—AKT1—breast cancer	3.34e-07	2.95e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—AKT1—breast cancer	3.34e-07	2.95e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—AKT1—breast cancer	3.13e-07	2.76e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CA—breast cancer	3.06e-07	2.7e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—AKT1—breast cancer	2.95e-07	2.61e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—AKT1—breast cancer	2.93e-07	2.58e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—AKT1—breast cancer	2.5e-07	2.21e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CA—breast cancer	2.36e-07	2.09e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AKT1—breast cancer	1.93e-07	1.7e-06	CbGpPWpGaD
